DXB 0.00% 11.0¢ dimerix limited

Competition in KD

  1. 48 Posts.
    lightbulb Created with Sketch. 21
    has anyone else considered the impact of the recent impressive results in kidney disease progression.

    the CREDENCE trial Released results at the major Australian Nephrology conference last week and announced some pretty amazing reductions in negative disease outcomes.

    I'm not a pharmacist so would be interested to know if anyone with relevant knowledge could speak to whether this treatment works on similar pathways, or if DXB-200 could work in unison.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
0.000(0.00%)
Mkt cap ! $17.46M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 29000 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 5000 1
View Market Depth
Last update - 16.12pm 19/07/2019 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.